Skip to content
After Hours Earnings Report for August 5, 2022: SLRX


JThe following companies are expected to report after-hours earnings on 08/05/2022. See our results calendar for a full list of expected results releases.

Salarius Pharmaceuticals, Inc. (SLRX) reports for the quarter ending June 30, 2022. The pharmaceutical company’s consensus earnings-per-share forecast from the top analyst tracking the stock is -$0.11. This value represents a decrease of 57.14% compared to the same quarter last year. Zacks Investment Research reports that the 2022 P/E ratio for SLRX is -0.43 versus an industry ratio of 2.60.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


nasdaq

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.